Information Provided By:
Fly News Breaks for January 14, 2020
Jan 14, 2020 | 08:06 EDT
Jefferies analyst Stephanie Wissink raised her price target on Medifast shares to $130 from $110 following her meeting with the company and their presentation at the ICR Xchange conference. The company disclosed a number of operational metrics not shared with the market previously, including 86% customer retention rates, which she believes point to its model differentiation, the analyst tells investors. She keeps a Buy rating on Medifast shares.
News For MED From the Last 2 Days
There are no results for your query MED